As filed with the Securities and Exchange Commission on December 21, 2023
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM F-3
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
THERATECHNOLOGIES INC.
(Exact name of Registrant as specified in its charter)
Not applicable
(Translation of Registrants name into English)
|
|
|
Québec, Canada |
|
98-0618426 |
(State or other Jurisdiction of
Incorporation or Organization) |
|
(I.R.S. Employer
Identification Number) |
2015 Peel Street, Suite 1100
Montréal, Québec H3A 1T8
Canada
(514) 336-7800
(Address and telephone number of Registrants principal executive offices)
PUGLISI & ASSOCIATES
850 Library Ave.
Newark,
DE 19711
(302) 738-6680
(Name, address, and telephone number of agent for service)
Copies of all communications, including communications sent to agent for service, should be sent to:
|
|
|
|
|
Jean-Pierre Chamberland
Fasken Martineau DuMoulin LLP
800 Victoria Square, Suite 3500
Montréal, Québec H3C OB4
Canada (514) 397-5186 |
|
Jocelyn Lafond
General Counsel and Corporate
Secretary Theratechnologies
Inc. 2015 Peel Street, Suite 1100
Montréal, Québec H3A 1T8
Canada (514) 336-7800 |
|
Martin Glass
Jenner & Block LLP
1155 Avenue of the Americas
New York, NY 10036
USA (212) 891-1672 |
Approximate date of commencement of proposed sale of the securities to the public: From time to time after the effective date of this
Registration Statement.
If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment
plans, please check the following box. ☐
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒
If this
Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration
statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective
upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☐
If this
Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the
following box. ☐
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405
of the Securities Act of 1933.
Emerging growth company ☒
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has
elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment that specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
|
The term new or revised financial accounting standard refers to any update issued by the Financial
Accounting Standards Board to its Accounting Standards Codification after April 5, 2012. |